ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency
Journal of Virology · 20.08.2024 · 98 (8)
DOI: 10.1128/jvi.00035-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, erschienen am 20.08.2024. Verfasst von Mo Zhou und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Virus Latency, HIV-1, HIV Long Terminal Repeat, HIV Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D program of department of science and technology of China, Important key program of natural science foundation of China, Guangdong basic and applied research foundation.
Abstract (Originalsprache)
The human immunodeficiency virus type 1 (HIV-1) reservoir consists of latently infected cells which present a major obstacle to achieving a functional cure for HIV-1. The formation and maintenance of HIV-1 latency have been extensively studied, and latency-reversing agents (LRAs) that can reactivate latent HIV-1 by targeting the involved host factors are developed; however, their clinical efficacies remain unsatisfactory. Therefore, it is imperative to identify novel targets for more potential candidates or better combinations for LRAs. In this study, we utilized CRISPR affinity purification in situ of regulatory elements system to screen for host factors associated with the HIV-1 long terminal repeat region that could potentially be involved in HIV-1 latency. We successfully identified that origin recognition complex 1 (ORC1), the largest subunit of the origin recognition complex, contributes to HIV-1 latency in addition to its function in DNA replication initiation. Notably, ORC1 is enriched on the HIV-1 promoter and recruits a series of repressive epigenetic elements, including DNMT1 and HDAC1/2, and histone modifiers, such as H3K9me3 and H3K27me3, thereby facilitating the establishment and maintenance of HIV-1 latency. Moreover, the reactivation of latent HIV-1 through ORC1 depletion has been confirmed across various latency cell models and primary CD4 + T cells from people living with HIV-1. Additionally, we comprehensively validated the properties of liquid-liquid phase separation (LLPS) of ORC1 from multiple perspectives and identified the key regions that promote the formation of LLPS. This property is important for the recruitment of ORC1 to the HIV-1 promoter. Collectively, these findings highlight ORC1 as a potential novel target implicated in HIV-1 latency and position it as a promising candidate for the development of novel LRAs. IMPORTANCE Identifying host factors involved in maintaining human immunodeficiency virus type 1 (HIV-1) latency and understanding their mechanisms prepares the groundwork to discover novel targets for HIV-1 latent infection and provides further options for the selection of latency-reversing agents in the “shock” strategy. In this study, we identified a novel role of the DNA replication factor origin recognition complex 1 (ORC1) in maintaining repressive chromatin structures surrounding the HIV-1 promoter region, thereby contributing to HIV-1 latency. This discovery expands our understanding of the non-replicative functions of the ORC complex and provides a potential therapeutic strategy for HIV-1 cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Center for Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Shenzhen Key Laboratory of Systems Medicine for Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China.
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Science), Guangzhou, China.
- Shenzhen Blood Center, Shenzhen, Guangdong, China.
- Guangzhou National Laboratory, Guangzhou International Bio-Island, Guangzhou, China.
ORCID-Profile: Mo Zhou, Lilin Wang, Xiancai Ma, Linghua Li, Bingfeng Liu, Hui Zhang
Förderung
- National Key R&D program of department of science and technology of China
- Important key program of natural science foundation of China
- Guangdong basic and applied research foundation
- Emergency key program of guangzhou national laboratory
- The national science foundation of China
- MOST | National Key Research and Development Program of China (NKPs)
- GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province ()
- Shenzhen blood center scientific research project
Zitieren
APA
Zhou, M., Yang, T., Yuan, M., Li, X., Deng, J., Wu, S., Zhong, Z., Lin, Y., Zhang, W., Xia, B., Wu, Y., Wang, L., Chen, T., Liu, R., Pan, T., Ma, X., Li, L., Liu, B., & Zhang, H. (2024). ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of Virology, 98(8). https://doi.org/10.1128/jvi.00035-24
Vancouver
Zhou M, Yang T, Yuan M, Li X, Deng J, Wu S, et al. ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of Virology. 2024;98(8). doi:10.1128/jvi.00035-24
BibTeX
@article{Zhou2024,
author = {Zhou, Mo and Yang, Tao and Yuan, Ming and Li, Xinyu and Deng, Jieyi and Wu, Shiyu and Zhong, Zhihan and Lin, Yingtong and Zhang, Wanying and Xia, Baijin and Wu, Yating and Wang, Lilin and Chen, Tao and Liu, Ruxin and Pan, Ting and Ma, Xiancai and Li, Linghua and Liu, Bingfeng and Zhang, Hui},
title = {ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency},
journal = {Journal of Virology},
year = {2024},
volume = {98},
number = {8},
doi = {10.1128/jvi.00035-24}
}
EUVIMED